Clinical Trial Update: Evaluation of the Clinical Performances of a Point of Care Analyzer Enabling Pre-transfusion ABOD Group Ultimate Verification at the Patient Bedside [NA]

View source ↗

Summary

A clinical trial evaluating a point-of-care ABO typing device for pre-transfusion verification at the patient bedside has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Transfusion Complication

Snippet

Sponsor: Francis Corazza | Conditions: Blood Transfusion Complication | NA | Status: WITHDRAWN